Crossmark

Impact of sarcopenia and changes in skeletal muscle mass on prognosis of patients with pancreatic ductal adenocarcinoma receiving chemotherapy with first-line gemcitabine and nab-paclitaxel: a prospective study

Crossref DOI link: https://doi.org/10.1007/s00535-025-02283-3

Published Online: 2025-07-17

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Emori, Tomoya

Itonaga, Masahiro

Ashida, Reiko

Ishihara, Tomokazu

Nakahata, Akiya

Kawaji, Yuki

Tamura, Takashi

Yamashita, Yasunobu

Fukatsu, Kazuhiro

Kitano, Masayuki https://orcid.org/0000-0001-6885-9223
License Information

Text and Data Mining valid from 2025-07-17

Version of Record valid from 2025-07-17
More Information

Article History

Received: 23 January 2025

Accepted: 2 July 2025

First Online: 17 July 2025

Declarations

:

: The authors declare no conflicts of interest regarding publication of this paper.

Document is current

Any future updates will be listed below